Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pike

Showing results (641-650 of 677) with videos related to

Pageof 68
Sort By:
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
International Journal of Epidemiology|July 13, 2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization studySuzanne C Dixon, Christina M Nagle, Aaron P Thrift, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingPaul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Human Molecular Genetics|January 7, 2016
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestryJonine D Figueroa, Candace D Middlebrooks, A Rouf Banday, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Nature Genetics|September 21, 2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Molecular Nutrition & Food Research|July 29, 2014
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma riskLinda E Kelemen, Kathryn L Terry, Marc T Goodman, et al.
British Journal of Cancer|March 21, 2018
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation studySuzanne C Dixon-Suen, Christina M Nagle, Aaron P Thrift, et al.
International Journal of Molecular Sciences|August 24, 2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous HistologyLinda E Kelemen, Madalene Earp, Brooke L Fridley, et al.
Pageof 68

Showing results (641-650 of 677) with videos related to

Sort By:
Pageof 68
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
International Journal of Epidemiology|July 13, 2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization studySuzanne C Dixon, Christina M Nagle, Aaron P Thrift, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingPaul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Human Molecular Genetics|January 7, 2016
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestryJonine D Figueroa, Candace D Middlebrooks, A Rouf Banday, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Nature Genetics|September 21, 2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Molecular Nutrition & Food Research|July 29, 2014
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma riskLinda E Kelemen, Kathryn L Terry, Marc T Goodman, et al.
British Journal of Cancer|March 21, 2018
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation studySuzanne C Dixon-Suen, Christina M Nagle, Aaron P Thrift, et al.
International Journal of Molecular Sciences|August 24, 2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous HistologyLinda E Kelemen, Madalene Earp, Brooke L Fridley, et al.
Pageof 68